COMMUNIQUÉS West-GlobeNewswire

-
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
18/06/2024 -
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
18/06/2024 -
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
18/06/2024 -
Pennant and Hartford HealthCare Partner to Transform Home Care Services
18/06/2024 -
Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference
18/06/2024 -
Capital Increase in Genmab as a Result of Employee Warrant Exercise
18/06/2024 -
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment
18/06/2024 -
SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
18/06/2024 -
"I Have Insurance, Why Can't I Afford My Oral Anticancer Medications?" International Myeloma Foundation Highlights the Urgent Need for Cancer Drug Parity Act at Congressional Briefing
18/06/2024 -
EssilorLuxottica and Diesel announce a ten-year licensing agreement
18/06/2024 -
EssilorLuxottica et Diesel annoncent un accord de licence de 10 ans
18/06/2024 -
Canadian Red Cross and The Resilience Institute launch new program to promote readiness
18/06/2024 -
La Croix-Rouge canadienne et le Resilience Institute s’unissent pour lancer un programme de préparation destiné aux communautés rurales, autochtones ou moins peuplées : Roots for Resilience
18/06/2024 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2024
18/06/2024 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2024
18/06/2024 -
Actions to strengthen presence in North Africa : Congress & Surgeons trainings
18/06/2024 -
Actions de développement de la zone Moyen-Orient : congrès et formation chirurgiens
18/06/2024 -
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
18/06/2024 -
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
18/06/2024
Pages